XML 58 R46.htm IDEA: XBRL DOCUMENT v3.25.3
GQ BIO THERAPEUTICS ACQUISITION - Schedule of Reconciliation of Purchase Price to Total Consideration Transferred (Details) - GQ Bio Acquisition - USD ($)
$ in Thousands
4 Months Ended
Feb. 27, 2025
Jun. 30, 2025
Feb. 25, 2025
Business Combination [Line Items]      
Cash consideration paid at closing $ 17,604    
Indemnification holdback 5,676 $ 5,700  
Cash payment of GQ Bio Acquisition transaction expenses 919    
Purchase price consideration of 81% of GQ Bio 30,576    
Prior 19% equity investment ownership of GQ Bio realized upon business combination 8,315    
Total fair value of the GQ Bio Acquisition 38,891    
Nonrelated Party      
Business Combination [Line Items]      
Settlement of previous amount 5,322    
Principal Owner      
Business Combination [Line Items]      
Settlement of previous amount $ 1,055    
GQ Bio Acquisition      
Business Combination [Line Items]      
Percentage of voting interests acquired 81.00%   81.00%
Ownership 19.00%